Brice R. Suire
Fondateur chez Priothera Ltd.
Profil
Brice R.
Suire is the founder of Priothera Ltd.
(founded in 2020) and Priothera SAS (founded in 2020) where he holds the title of Chief Financial Officer.
He previously worked as a Principal at Mazars SA, Audit Manager at Novartis Biociências SA, Principal at Price Waterhouse y Audiberia SA, Head-Finance at Novartis Institutes for Biomedical Research, Inc., Global Head-Finance Supply Chain at Novartis Pharmaceuticals, and Chief Financial Officer at MyoPowers Medical Technologies France SAS.
Mr. Suire obtained an undergraduate degree from Université Paris Dauphine-PSL.
Postes actifs de Brice R. Suire
| Sociétés | Poste | Début |
|---|---|---|
Priothera Ltd.
 Priothera Ltd. BiotechnologyHealth Technology Priothera Ltd. engages in the development of orally delivered sphingosine-1-phosphate (S1P) receptor modulators for hematological malignancies. The company was founded by Florent Gros, Shaval Patel, and Brice Suire in 2020 and is headquartered in Dublin, Ireland. | Fondateur | 01/01/2020 |
Priothera SAS
 Priothera SAS BiotechnologyHealth Technology Part of Priothera Ltd., Priothera SAS is a French company dedicated to improving the lives of patients suffering from hematological malignancies by delivering an innovative immune modulator to enhance the curative potential of both allogeneic hematopoietic stem cell transplantation (HSCT) and CAR-T cell therapy. The company is based in Saint-Louis, France. Priothera is leading the way in developing Mocravimod, a S1P receptor modulator as an adjunctive and maintenance immune therapy to allo-HSCT and to CAR-T. Mocravimod has the potential to reduce the occurrence of (acute) GVHD without suppressing T cell function, thus GVL is maintained. Priothera is developing Mocravimod (KRP203) to significantly improve the clinical outcome of allo-HSCT and CAR-T therapy. The company was founded in 2020 by Philippe Lievre, Florent Gros, Brice R. Suire, Stephan Oehen, Simone Seiter. Florent Gros has been the CEO since 2020. | Fondateur | 30/09/2020 |
Anciens postes connus de Brice R. Suire
| Sociétés | Poste | Fin |
|---|---|---|
Novartis Biociências SA
 Novartis Biociências SA Pharmaceuticals: GenericHealth Technology Novartis Biociências SA produces and markets generic drugs. Its solutions include generic and similar drugs, eye care products, and research. The company was founded on July 27, 1966 and is headquartered in Sao Paulo, Brazil. | Comptroller/Controller/Auditor | - |
Price Waterhouse y Audiberia SA
 Price Waterhouse y Audiberia SA Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., Price Waterhouse y Audiberia SA is a Spanish company. | Corporate Officer/Principal | - |
Mazars SA
 Mazars SA Miscellaneous Commercial ServicesCommercial Services Mazars SA provides auditing, financial, and legal services. It specializes in accounting, risk management, corporate strategy, litigation counseling, and taxation. It serves the finance, insurance, real estate, manufacturing, distribution, media, and healthcare sectors. The company was founded by Robert Mazars in 1940 and is headquartered in Courbevoie, France. | Corporate Officer/Principal | - |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Novartis Pharmaceuticals
 Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The company is based in Basel, Germany. | Directeur Financier/CFO | 10/01/2013 |
Formation de Brice R. Suire
| Université Paris Dauphine-PSL | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
MyoPowers Medical Technologies France SAS
 MyoPowers Medical Technologies France SAS Medical SpecialtiesHealth Technology MyoPowers Medical Technologies France SA operates as a medical device company. It specializes in muscle technologies to restore or improve muscle function. The firm also develops implantable medical devices for the treatment of severe stress urinary incontinence. The company was founded by Piergiorgio Tozzi and Daniel Hyoz in June 2004 and is headquartered in Lausanne, Switzerland. | Health Technology |
Novartis Pharmaceuticals
Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals is a German company that manufactures pharmaceutical products. The company is based in Basel, Germany. | Health Technology |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
Mazars SA
Mazars SA Miscellaneous Commercial ServicesCommercial Services Mazars SA provides auditing, financial, and legal services. It specializes in accounting, risk management, corporate strategy, litigation counseling, and taxation. It serves the finance, insurance, real estate, manufacturing, distribution, media, and healthcare sectors. The company was founded by Robert Mazars in 1940 and is headquartered in Courbevoie, France. | Commercial Services |
Price Waterhouse y Audiberia SA
Price Waterhouse y Audiberia SA Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., Price Waterhouse y Audiberia SA is a Spanish company. | Commercial Services |
Novartis Biociências SA
Novartis Biociências SA Pharmaceuticals: GenericHealth Technology Novartis Biociências SA produces and markets generic drugs. Its solutions include generic and similar drugs, eye care products, and research. The company was founded on July 27, 1966 and is headquartered in Sao Paulo, Brazil. | Health Technology |
Priothera Ltd.
Priothera Ltd. BiotechnologyHealth Technology Priothera Ltd. engages in the development of orally delivered sphingosine-1-phosphate (S1P) receptor modulators for hematological malignancies. The company was founded by Florent Gros, Shaval Patel, and Brice Suire in 2020 and is headquartered in Dublin, Ireland. | Health Technology |
Priothera SAS
Priothera SAS BiotechnologyHealth Technology Part of Priothera Ltd., Priothera SAS is a French company dedicated to improving the lives of patients suffering from hematological malignancies by delivering an innovative immune modulator to enhance the curative potential of both allogeneic hematopoietic stem cell transplantation (HSCT) and CAR-T cell therapy. The company is based in Saint-Louis, France. Priothera is leading the way in developing Mocravimod, a S1P receptor modulator as an adjunctive and maintenance immune therapy to allo-HSCT and to CAR-T. Mocravimod has the potential to reduce the occurrence of (acute) GVHD without suppressing T cell function, thus GVL is maintained. Priothera is developing Mocravimod (KRP203) to significantly improve the clinical outcome of allo-HSCT and CAR-T therapy. The company was founded in 2020 by Philippe Lievre, Florent Gros, Brice R. Suire, Stephan Oehen, Simone Seiter. Florent Gros has been the CEO since 2020. | Health Technology |
